UPDATE : Friday, December 13, 2019
상단여백
Local drugmakers speed up NASH drug development by Lee Hye-seon 2019-08-16 13:52
Last trial OKed for Eylea to prevent blindness in premature infants by Lee Hye-seon 2019-08-13 12:42
Yuhan can continue testing lung cancer drug Lazertinib by Lee Hye-seon 2019-08-12 12:58
Drug regulator to enhance clinical trial management by 2023 by Lee Hye-seon 2019-08-08 14:55
New weight loss drug Qsymia wins local approval by Lee Hye-seon 2019-08-01 10:57
라인
One in 45 Koreans prescribed with diet pills by Lee Hye-seon 2019-07-30 15:44
Rare Fabry disease depicted in K-dramas by Lee Hye-seon 2019-07-30 12:40
Top-30 makers produce more than half of drugs by Lee Hye-seon 2019-07-29 16:38
Government employee stages one-person protest against own ministry by Lee Hye-seon 2019-07-18 17:07
Ministry extends data submission for cell therapy CureSkin by Lee Hye-seon 2019-07-15 14:35
라인
Ministry to request investigation into Meditoxin approval process by Lee Hye-seon 2019-07-12 16:29
Acute renal failure reported in ibandronate injections by Lee Hye-seon 2019-07-11 13:34
Pfizer fails to cut participants in Xeljanz’ post-marketing surveillance by Lee Hye-seon 2019-07-08 16:39
Kolon confident to resume US trial on Invossa by Lee Hye-seon 2019-07-04 14:05
Regulator revokes Invossa license; Kolon CEO ‘to fight in court’ by Lee Hye-seon 2019-07-03 11:52
라인
26 new drugs approved in H1 by Lee Hye-seon 2019-07-02 14:31
Multinationals face suspension of drug imports by Lee Hye-seon 2019-07-01 14:12
Government to help cover costs for injuries from side effects by Lee Hye-seon 2019-06-28 12:30
Samsung Bioepis readies phase-3 trial on Soliris biosimilar by Lee Hye-seon 2019-06-27 17:14
False ads of ‘hair loss treatments’ got caught by Lee Hye-seon 2019-06-27 16:42
여백
여백
여백
Back to Top